The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Changes In Market Value Are Expected For The Hospital-Acquired Infection Control Market Over The 2026–2030 Period?
The market for hospital-acquired infection control has exhibited robust growth in recent years. It is projected to expand from $35.75 billion in 2025 to $37.7 billion in 2026, maintaining a compound annual growth rate (CAGR) of 5.4%. This historical growth can be attributed to a surge in hospital-acquired infections, an increased adoption of invasive medical procedures, heightened awareness concerning patient safety standards, the expansion of intensive care units, and more rigorous hospital hygiene regulations.
The hospital-acquired infection control market is projected for substantial growth over the next few years, with expectations to reach $46.32 billion by 2030 at a compound annual growth rate (CAGR) of 5.3%. This anticipated growth is driven by factors such as increasing regulatory enforcement concerning infection control, a rise in the adoption of automated sterilization technologies, a growing demand for rapid microbial testing, the expansion of surveillance and reporting systems, and increasing investments in hospital infection prevention infrastructure. Major trends during this period will include an intensified focus on preventing cross-contamination within hospitals, the rising adoption of advanced sterilization and disinfection protocols, a growing emphasis on continuous infection surveillance, the expansion of automated and high-level disinfection solutions, and an increasing demand for comprehensive infection prevention programs.
Access Your Free Sample Report For In-Depth Market Analysis:
What Key Factors Are Affecting The Hospital-Acquired Infection Control Market Demand?
Rising healthcare expenditures are projected to drive the expansion of the hospital-acquired infection control market. Healthcare expenditures refer to the total financial outlay for healthcare-related services, products, and activities within a specified timeframe, typically at an individual, community, national, or global level. With an increase in healthcare spending, hospitals and healthcare facilities are set to allocate additional resources for adopting advanced infection prevention technologies, encompassing innovative solutions such as advanced disinfection systems, smart monitoring devices, and other technologies that enhance overall infection control measures. For example, in May 2024, data from the Office for National Statistics, a UK-based government department, indicated that total healthcare expenditure increased by 5.6% in nominal terms between 2022 and 2023, a significant rise compared with the 0.9% growth recorded in 2022. Therefore, increasing healthcare expenditure will propel the growth of the hospital-acquired infection control market going forward.
What Are The Key Segment Divisions In The Hospital-Acquired Infection Control Market Segment Structure?
The hospital-acquired infection control market covered in this report is segmented –
1) By Product: Sterilizers, Disinfectors, Endoscope Reprocessors, Microbial Testing Instruments, Consumables, Disinfectants, Infection Prevention And Surveillance Software, Other Products
2) By Technology: Phenotypic Methods, Genotypic Methods
3) By Diseases: Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infection, Other Diseases
4) By Application: Disease Testing, Drug-Resistance Testing
5) By End User: Hospitals, ICUs, Ambulatory Surgical, Diagnostic Centers, Nursing Homes, Maternity Centers, Other End Users
Subsegments:
1) By Sterilizers: Steam Sterilizers, Ethylene Oxide Sterilizers, Hydrogen Peroxide Sterilizers
2) By Disinfectors: Washer Disinfectors, Automated Disinfectors
3) By Endoscope Reprocessors: High-Level Disinfection Reprocessors, Automated Endoscope Reprocessors
4) By Microbial Testing Instruments: Culture Systems, Rapid Microbial Testing Systems
5) By Consumables: Sterilization Wraps, Filters, Personal Protective Equipment (PPE)
6) By Disinfectants: Alcohol-based Disinfectants, Chlorine-based Disinfectants, Quaternary Ammonium Compounds
7) By Infection Prevention And Surveillance Software: Surveillance Software Solutions, Data Management Software
8) By Other Products: Cleaning Equipment, Air Purification Systems
What Trends Are Influencing Changes In The Hospital-Acquired Infection Control Market?
Key players in the hospital-acquired infection control market are prioritizing the development of innovative technological solutions, including AI systems, to enable early sepsis identification and enhance patient outcomes through rapid diagnosis and treatment. An AI system designed to identify sepsis involves advanced technological approaches that leverage artificial intelligence and machine learning algorithms to detect initial signs of sepsis in individuals. For instance, in April 2024, Prenosis Inc., a US-based medical clinic, secured FDA marketing authorization for the Sepsis ImmunoScore, which stands as the inaugural AI-driven system engineered to predict sepsis, a critical condition that can result in serious complications. This cutting-edge tool boosts early detection by analyzing real-time data, allowing medical professionals to intervene more quickly and efficiently. The integration of AI is intended to support healthcare staff in their decision-making rather than substituting their roles, ultimately leading to improved patient outcomes and reduced healthcare costs.
Which Organizations Are Engaged In The Hospital-Acquired Infection Control Market?
Major companies operating in the hospital-acquired infection control market are Johnson and Johnson, P&G Professional, Honeywell International Inc., MMM Group, 3M Company, Becton Dickinson and Company, Reckitt Benckiser Group plc., Ecolab Inc, Olympus Corporation, Miele Group, Biomerieux SA, Getinge AB, Halyard Health Inc., Ansell Limited, Sotera Health LLC, Contec Inc., Cantel Medical Corp., Belimed AG, Nanosonics Limited, Advanced Sterilization Products Services Inc, Steelco S.P.A, Schülke & Mayr GmbH, Metrex Research LLC, Tristel Solutions Ltd., Whiteley Corporation, PDI Inc., Steris Healthcare PVT Ltd, Matachana Group, Pal International Ltd., Xttrium Laboratories Inc., Zep Inc.
Get The Full Hospital-Acquired Infection Control Market Report:
Which Region Leads The Hospital-Acquired Infection Control Market In Terms Of Market Share?
North America was the largest region in the hospital-acquired infection control market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital-acquired infection control market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Hospital-Acquired Infection Control Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Hospital-Acquired Infection Control Market 2026, By The Business Research Company
Infection Control Supplies Market Report 2026
https://www.thebusinessresearchcompany.com/report/infection-control-supplies-global-market-report
Infection Control Market Report 2026
https://www.thebusinessresearchcompany.com/report/infection-control-global-market-report
Surgical Site Infection Control Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model